These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30998692)

  • 1. Head-to-head comparison of three stool calprotectin tests for home use.
    Haisma SM; Galaurchi A; Almahwzi S; Adekanmi Balogun JA; Muller Kobold AC; van Rheenen PF
    PLoS One; 2019; 14(4):e0214751. PubMed ID: 30998692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
    Vinding KK; Elsberg H; Thorkilgaard T; Belard E; Pedersen N; Elkjaer M; Marker D; Carlsen K; Burisch J; Munkholm P
    Inflamm Bowel Dis; 2016 Feb; 22(2):336-44. PubMed ID: 26535869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease.
    Lerchova T; Hradsky O; Copova I; Potuznikova K; Gonsorcikova L; Bronsky J
    J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):75-81. PubMed ID: 30908389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IBDoc Canadian User Performance Evaluation.
    Moore AC; Huang VW; Bourdages R; Fedorak RN; Reinhard C; Leung Y; Bressler B; Rosenfeld G
    Inflamm Bowel Dis; 2019 May; 25(6):1107-1114. PubMed ID: 30535387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A; D'Incà R; Scapellato ML; De Bastiani R; Caccaro R; Mescoli C; Moz S; Bozzato D; Zambon CF; Lorenzon G; Rugge M; Plebani M; Basso D
    Clin Chem Lab Med; 2018 Oct; 56(11):1926-1935. PubMed ID: 29729144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Calprotectin Test Performed at Home: A Prospective Study of Pediatric Patients With Inflammatory Bowel Disease.
    Piekkala M; Alfthan H; Merras-Salmio L; Puustinen Wikström A; Heiskanen K; Jaakkola T; Klemetti P; Färkkilä M; Kolho KL
    J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):926-931. PubMed ID: 29240011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal calprotectin: assessment of a rapid test.
    Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
    Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 13. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
    De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
    Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Quantum Blue® rapid test for faecal calprotectin.
    Wassell J; Wallage M; Brewer E
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):55-8. PubMed ID: 21930735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
    Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Two Calprotectin Rapid Tests in Daily Routine.
    Schulz C; Wex T; Arnim UV; Malfertheiner P
    Clin Lab; 2016 Jul; 62(7):1249-1254. PubMed ID: 28164652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
    Noebauer B; Ramic L; Konstantin A; Zachbauer C; Einwallner E
    Biochem Med (Zagreb); 2017 Oct; 27(3):030710. PubMed ID: 29180918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
    Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.